# Seattle Reproductive Medicine, Inc., P.S. – FDA Inspection, Oct 24, 2017

Source: https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/87978760-7c8a-4f8f-9964-6f62749fb63c
Source feed: FDA_Inspections

> FDA inspection 1031414 of Seattle Reproductive Medicine, Inc., P.S., October 24, 2017. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031414
- Company Name: Seattle Reproductive Medicine, Inc., P.S.
- Inspection Date: 2017-10-24
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1293422 - 2025-09-16
- FDA Inspection 1171334 - 2022-04-07
- FDA Inspection 961640 - 2016-02-10
- FDA Inspection 865541 - 2014-02-10

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/peter-s-kessler/f3a9dea7-3a2d-4c86-9ec6-97791f9b6c21)

Company: https://www.keypedia.com/companies/seattle-reproductive-medicine-inc-ps/a65e1f0e-6645-4092-a3d7-cce342cdd872

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d